Choline salicylate Interactions
There are 244 drugs known to interact with choline salicylate, along with 8 disease interactions. Of the total drug interactions, 13 are major, 196 are moderate, and 35 are minor.
- View all 244 medications that may interact with choline salicylate
- View choline salicylate disease interactions (8)
Most frequently checked interactions
View interaction reports for choline salicylate and the medicines listed below.
- Activated Charcoal (charcoal)
- Activated Charcoal (charcoal)
- Adacel (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- Adacel (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- Albuminar-20 (albumin human)
- Albuminar-20 (albumin human)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Alcohol (contained in alcoholic beverages) (ethanol)
- AstraZeneca COVID-19 Vaccine (sars-cov-2 (covid-19) chadox1 vaccine, recombinant)
- AstraZeneca COVID-19 Vaccine (sars-cov-2 (covid-19) chadox1 vaccine, recombinant)
- Boostrix (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- Boostrix (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Copper (copper gluconate)
- Glycerol (glycerin)
- Glycerol (glycerin)
- Metoprolol Tartrate (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Quercetin (bioflavonoids)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
- Vitamin K2 (menaquinone)
Choline salicylate disease interactions
There are 8 disease interactions with choline salicylate which include:
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.